TY - JOUR T1 - Model training periods impact estimation of COVID-19 incidence from wastewater viral loads JF - medRxiv DO - 10.1101/2022.07.16.22276772 SP - 2022.07.16.22276772 AU - Maria L. Daza–Torres AU - J. Cricelio Montesinos-López AU - Minji Kim AU - Rachel Olson AU - C. Winston Bess AU - Lezlie Rueda AU - Mirjana Susa AU - Linnea Tucker AU - Yury E. García AU - Alec J. Schmidt AU - Colleen Naughton AU - Brad H. Pollock AU - Karen Shapiro AU - Miriam Nuño AU - Heather N. Bischel Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/07/18/2022.07.16.22276772.abstract N2 - Background Wastewater-based epidemiology (WBE) has been deployed broadly as an early warning tool for emerging COVID-19 outbreaks. WBE can inform targeted interventions and identify communities with high transmission, enabling quick and effective response. As wastewater becomes an increasingly important indicator for COVID-19 transmission, more robust methods and metrics are needed to guide public health decision making.Objectives The aim of this research was to develop and implement a mathematical framework to infer incident cases of COVID-19 from SARS-CoV-2 levels measured in wastewater. We propose a classification scheme to assess the adequacy of model training periods based on clinical testing rates and assess the sensitivity of model predictions to training periods.Methods We present a Bayesian deconvolution method and linear regression to estimate COVID-19 cases from wastewater data. We described an approach to characterize adequacy in testing during specific time periods and provided evidence to highlight the importance of model training periods on the projection of cases. We estimated the effective reproductive number (Re) directly from observed cases and from the reconstructed incidence of cases from wastewater. The proposed modeling framework was applied to three Northern California communities served by distinct wastewater treatment plants.Results Both deconvolution and linear regression models consistently projected robust estimates of prevalent cases and Re from wastewater influent samples when assuming training periods with adequate testing. Case estimates from models that used poorer-quality training periods consistently underestimated observed cases.Discussion Wastewater surveillance data requires robust statistical modeling methods to provide actionable insight for public health decision-making. We propose and validate a modeling framework that can provide estimates of COVID-19 cases and Re from wastewater data that can be used as tool for disease surveillance including quality assessment for potential training data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the Healthy Central Valley Together (HCVT) and Healthy Davis Together (HDT) programs at the University of California, Davis. This research was also supported in part by the NIH Rapid Acceleration of Diagnostics (RADxSM) initiative with federal funds from the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health. The current contract is funded from the Public Health and Social Services Emergency Fund through the Biomedical Advanced Research and Development Authority, HHS Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, under Contract No. 75N92021C00012.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was determined to be exempt from institutional review board review by the University of California Davis Office of Research. IRB ID: 1932632-1.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. ER -